Geovax Labs Inc. (GOVX)
NASDAQ (CM) NASDAQ (CM) Primary 
GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript
GeoVax Labs, Inc. (NASDAQ:GOVX ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Max Gadicke - Investor Relations David Dodd - Chairman & Chief Executive Officer Mark Reynolds - Chief Financial Officer Kelly McKee - Chief Medical Officer Conference Call Participants Robert LeBoyer - Noble Capital Markets Jason Kolbert - EF Hutton Jeff Kraws - Crystal Research Operator Good afternoon and welcome everyone to the GeoVax Second Quarter 2024 Corporate Update Call. My name is Alex and I will facilitate today's call.
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
Geovax Labs (NASDAQ: GOVX ) stock is jumping on Tuesday as investors in GOVX prepare for a catalyst on July 18. That's when Geovax Labs will hold a presentation at the Emerging Growth Conference.
Why Is GeoVax (GOVX) Stock Up 110% Today?
Biotechnology specialist GeoVax (NASDAQ: GOVX ) — which focuses on developing immunotherapies and vaccines against cancers and infectious diseases — just announced a partnership with global clinical research organization Allucent. The main purpose behind the agreement is to conduct a Phase 2b clinical trial of GeoVax's next-generation Covid-19 vaccine.
